• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

3

CATEGORIES

  • 32
  • 31
  • 16
  • 13
  • 4
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

31
31
67
106

PUBLISHED

0
0
16
106

PRODUCT TYPE

105
1

Search "VaxGen Incorporated" returned 106 results.

Dengue - Pipeline Review, H2 2013

Dengue - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Dengue - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

September 2013
FROM

Influenza - Pipeline Review, H2 2013

Influenza - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Influenza - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

August 2013
FROM

Herpes Simplex Infections - Pipeline Review, H1 2015

Herpes Simplex Infections - Pipeline Review, H1 2015 Summary This, ‘Herpes Simplex Infections - Pipeline Review, H1 2015’, provides an overview of the Herpes Simplex Infections’s therapeutic pipeline. This...

March 2015
FROM
Dengue - Pipeline Review, H1 2013 Dengue - Pipeline Review, H1 2013 - Product Thumbnail Image

Dengue - Pipeline Review, H1 2013

Dengue – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Dengue - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

March 2013
FROM

Herpes Simplex Infections - Pipeline Review, H2 2013

Herpes Simplex Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Herpes Simplex Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

September 2013
FROM

Melanoma - Pipeline Review, H2 2013

Melanoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Melanoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

August 2013
FROM

Allergic Rhinitis - Pipeline Review, H2 2013

Allergic Rhinitis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Allergic Rhinitis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

August 2013
FROM

HIV / AIDS – Pipeline Review, H1 2013

Global Markets Direct’s, 'HIV / AIDS - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline This report provides information on the therapeutic development for HIV...

February 2013
FROM

Fallopian Tube Cancer - Pipeline Review, H1 2015

Fallopian Tube Cancer - Pipeline Review, H1 2015 Summary This, ‘Fallopian Tube Cancer - Pipeline Review, H1 2015’, provides an overview of the Fallopian Tube Cancer’s therapeutic pipeline. This report...

March 2015
FROM

Herpes Simplex Infections - Pipeline Review, H1 2014

Herpes Simplex Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Herpes Simplex Infections - Pipeline Review, H1 2014’, provides an overview of the Herpes Simplex Infections’s...

March 2014
FROM

HIV / AIDS - Pipeline Review, H2 2013

HIV / AIDS - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'HIV / AIDS - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

July 2013
FROM

Hepatitis B - Pipeline Review, H1 2013

Hepatitis B – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Hepatitis B - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

May 2013
FROM

Atherosclerosis - Pipeline Review, H2 2013

Atherosclerosis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Atherosclerosis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

August 2013
FROM

Tuberculosis - Pipeline Review, H2 2014

Tuberculosis - Pipeline Review, H2 2014 Summary This, ‘Tuberculosis - Pipeline Review, H2 2014’, provides an overview of the Tuberculosis’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Hepatitis C - Pipeline Review, H2 2013

Hepatitis C - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Hepatitis C - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

August 2013
FROM
Dengue - Pipeline Review, H2 2012 Dengue - Pipeline Review, H2 2012 - Product Thumbnail Image

Dengue - Pipeline Review, H2 2012

Dengue – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Dengue - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information...

September 2012
FROM
Gram-Positive Bacterial Infections - Pipeline Review, H1 2013 Gram-Positive Bacterial Infections - Pipeline Review, H1 2013 - Product Thumbnail Image

Gram-Positive Bacterial Infections - Pipeline Review, H1 2013

Gram-Positive Bacterial Infections – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Gram-Positive Bacterial Infections - Pipeline Review, H1 2013', provides an overview of the indication’s...

April 2013
FROM

Skin Cancer - Pipeline Review, H1 2013

Skin Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Skin Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

May 2013
FROM

Pancreatic Cancer - Pipeline Review, H1 2014

Pancreatic Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2014’, provides an overview of the Pancreatic Cancer’s therapeutic pipeline. This...

May 2014
FROM

Alzheimer's Disease - Pipeline Review, H2 2013

'Alzheimer's Disease - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic development for Alzheimer's Disease,...

August 2013
FROM
Loading Indicator

Our Clients

Carrefour S.A. Dow Chemical Co Ltd. Motorola Solutions, Inc. Pfizer, Inc. Activision Publishing, Inc. 3M Company Estée Lauder Companies Inc.